Noyada 5mg/5ml oral solution

Država: Velika Britanija

Jezik: engleski

Izvor: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivni sastojci:

Captopril

Dostupno od:

Martindale Pharmaceuticals Ltd

ATC koda:

C09AA01

INN (International ime):

Captopril

Doziranje:

1mg/1ml

Farmaceutski oblik:

Oral solution

Administracija rute:

Oral

Razred:

No Controlled Drug Status

Tip recepta:

Valid as a prescribable product

Proizvod sažetak:

BNF: 02050501; GTIN: 5026468754182

Uputa o lijeku

WHAT IS IN THIS LEAFLET
1. What Noyada Oral Solution is and what it is used
for
2. What you need to know before you take Noyada
Oral Solution
3. How to take Noyada Oral Solution
4. Possible side effects
5. How to store Noyada Oral Solution
6. Contents of the pack and other information
1. WHAT NOYADA ORAL SOLUTION IS AND
WHAT IT IS USED FOR
Noyada Oral Solution contains the active substance
captopril which belongs to the group of
medicines called Angiotensin Converting Enzyme
(ACE) Inhibitors. ACE inhibitors work by helping to
widen your blood vessels, which then make it easier
for your heart to pump blood through them.
Captopril is used to treat the following in adults, the
elderly and children:
• High blood pressure and certain heart conditions.
If high blood pressure is left uncontrolled it
can increase the risk of heart disease or stroke.
Captopril works by lowering your blood pressure
which reduces this risk.
• People whose heart no longer pumps blood as
well as it once did. This condition is known as heart
failure.
• People who have recently suffered a heart attack.
A heart attack happens once one of the major
blood vessels supplying blood to the heart muscle
becomes blocked. This means that the heart does
not receive the oxygen it needs and the heart
muscle becomes damaged.
• Kidney disease in people with diabetes.
2 WHAT YOU NEED TO KNOW BEFORE YOU
TAKE NOYADA ORAL SOLUTION
DO NOT TAKE NOYADA ORAL SOLUTION IF:
• you are allergic (hypersensitive) to captopril,
any other ACE inhibitors, or any of the other
ingredients of this medicine (listed in section 6 of
this leaflet)
• you or any members of your family have ever had a
reaction which included swelling of the hands, lips,
face or tongue where the cause was unknown
• you are more than 3 months pregnant (it is better
to avoid Noyada Oral Solution in early pregnancy
(see Pregnancy section).
• you have diabetes or impaired kidney function and
you are treated with a blood pressure lowering
medicine containing aliskiren
If any of the above appli

Svojstava lijeka

OBJECT 1
NOYADA 5MG/5ML ORAL SOLUTION
Summary of Product Characteristics Updated 05-Jul-2017 | Martindale
Pharma
1. Name of the medicinal product
Noyada 5mg/5ml Oral Solution
2. Qualitative and quantitative composition
Each ml of 5mg/5ml oral solution contains 1mg captopril.
This medicinal product contains 2.3 mmol (or 53.38 mg) sodium per
maximum daily dose.
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Oral solution
Clear, colourless solution.
4. Clinical particulars
4.1 Therapeutic indications
_Hypertension: _Noyada oral solution is indicated for the treatment of
hypertension.
_Heart Failure: _Noyada oral solution is indicated for the treatment
of chronic heart failure with reduction
of systolic ventricular function, in combination with diuretics and,
when appropriate, digitalis and beta-
blockers.
_Myocardial Infarction:_
- _short-term (4 weeks) treatment: _Noyada oral solution is indicated
in any clinically stable patient within
the first 24 hours of an infarction.
- _long-term prevention of symptomatic heart failure: _Noyada oral
solution is indicated in clinically stable
patients with asymptomatic left ventricular dysfunction (ejection
fraction equal to or below 40%).
_Type I Diabetic Nephropathy: _Noyada oral solution is indicated for
the treatment of macroproteinuric
diabetic nephropathy in patients with type I diabetes. (See section
5.1).
_Noyada oral solution can be used alone or in combination with other
antihypertensive agents (see _
_sections 4.3, 4.4, 4.5 and 5.1)._
4.2 Posology and method of administration
Noyada Oral Solution is available in two strengths 5mg/5ml and
25mg/5ml;
For lower doses that include fractions of a mg, the 5mg/5ml product
should be used.
For higher doses the 25mg/5ml product is recommended.
The following table provides a guide for using Noyada 5mg/5ml or
Noyada 25mg/5ml for most common
dose.
Dose
Noyada 5mg/5ml
Noyada 25mg/5ml
Adult population
6.25 mg
6.25ml
12.5 mg
12.5 ml
25 mg
5ml
37.5 mg
7.5ml
50mg
10ml
75mg
15ml
100mg
20ml
150mg
30ml
Paediatric